BofA Securities Starts Fractyl Health Inc (GUTS) at Buy, 'novel diabesity treatment alternatives to chronic GLP1 therapy'
Tweet Send to a Friend
(Updated - February 27, 2024 6:09 AM EST)
BofA Securities analyst Jason Gerberry initiates coverage on Fractyl Health Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Jason Gerberry initiates coverage on Fractyl Health Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
